HopeStage
Back to all studies
RecruitingNCT05663489

Tracking brain and symptom changes during four-day exposure treatment for OCD and anxiety

About this titleRead the official source — NCT05663489
Observational studyAges 16+Norway
The study in practice

Understand this study

Who could participate?

Listed age limits: from 16 years.

Listed locations
BergenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 23, 2018
Recruitment status
Recruiting
Enrollment listed in the registry
500
Sponsor
Haukeland University Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Norway
Age range
Over 16 Years
Official registry ID
NCT05663489
Official title
Show the full official title

Neurobiological Markers of Treatment Response for Anxiety and OCD

Recruitment & locations

Currently recruiting

Bergen

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Haukeland University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: from 16 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies